Primary Site >> Colorectal Cancer
Gene >> OLFM4
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa. PMID: 11302958 |
Ref: Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. PMID: 18798264 |
Ref: OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. PMID: 19450592 |
Ref: Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. PMID: 20479215 Ref: Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancer. PMID: 23136596 |
Ref: A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. PMID: 21986994 Ref: Myb controls intestinal stem cell genes and self-renewal. PMID: 21997934 |
Ref: Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients. PMID: 22011044 Ref: EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patients. PMID: 22047082 |
Ref: In situ validation of an intestinal stem cell signature in colorectal cancer. PMID: 22637696 Ref: Expression of olfactomedin 4 and claudin-18 in serrated neoplasia of the colorectum: a characteristic pattern is associated with sessile serrated lesion. PMID: 23570326 Ref: Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. PMID: 24009080 Ref: New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers. PMID: 24101199 |
Ref: In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. PMID: 24681409 Ref: N-glycoprotein analysis discovers new up-regulated glycoproteins in colorectal cancer tissue. PMID: 25247386 Ref: Tripartite interactions between Wnt signaling, Notch and Myb for stem/progenitor cell functions during intestinal tumorigenesis. PMID: 25290188 Ref: The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018). PMID: 25510341 |
Ref: Expression of GW112 and GRIM-19 in colorectal cancer tissues. PMID: 26011333 Ref: Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer. PMID: 26416558 |
Ref: Distribution of intestinal stem cell markers in colorectal precancerous lesions. PMID: 26212207 Ref: Olfactomedin 4 deletion induces colon adenocarcinoma in Apc(Min/+) mice. PMID: 26973250 |
Ref: Prognostic significance of stromal GREM1 expression in colorectal cancer. PMID: 28041973 Ref: Peripheral blood leucocytes show differential expression of tumour progression-related genes in colorectal cancer patients who have a postoperative intra-abdominal infection: a prospective matched cohort study. PMID: 28214365 Ref: OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages. PMID: 28344541 Ref: NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer. PMID: 28598238 Ref: Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases. PMID: 28669815 |
Ref: Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis. PMID: 29203393 Ref: Olfactomedin-4 in digestive diseases: A mini-review. PMID: 29740203 |